Cardinal Health Inc vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Cardinal Health Inc trades at $229.11 (market cap $53.89B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.81. The key difference: Cardinal Health Inc pays a 0.89% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| CAH | HYG | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Fixed Income |
52-Week High | $239.71 | $81.32 |
52-Week Low | $146.04 | $78.72 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
HYG trades at $79.52, down 0.24% with a bearish technical outlook indicated by 17 sell signals against 2 buy signals. The ETF maintains dividend distributions, with recent payouts of $0.42 in May 2026 and $0.41 in June 2026. Market sentiment is cautious amid Federal Reserve uncertainty and elevated put volume in high-yield bonds, reflecting investor concerns about interest rate hikes and inflation pressures.
Outlook remains challenged by macroeconomic headwinds and potential Fed tightening, though dividend yield provides income support. Key risks include interest rate volatility and narrowing market breadth. Investors should weigh yield attractiveness against duration risk in a rising rate environment.
Trailing returns across standard periods
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →